First-in-Class Dual HIF Inhibitors Eradicate Breast, Colorectal, Melanoma, and Prostate Tumors in Mice Combined with Immunotherapy
A groundbreaking breakthrough in cancer therapeutics has emerged from a collaboration between Johns Hopkins University and the University of Maryland ...
